To learn more about our prospective biomarker study please click here.
Idylla™ ctEGFR Available Now! Click here for more information

AMP 2019

November 7-9, 2019 | Baltimore Convention Center


BOOTH #2840

Get firsthand perspectives on how Idylla™ can help streamline workflows for your oncology samples and improve turnaround times in virtually any lab at the Biocartis Corporate Workshop!

Make sure to stop by our booth (#2840)! We will be providing live demos of Idylla™, our fully-automated molecular testing platform.


AMP 2019 Annual Meeting

Wed, Nov 07 | Baltimore Convention Center
November 7 - 9, 2019 | Baltimore Convention Center

The AMP Annual Meeting has truly become pathology’s global event. Decision makers in the field of pathology and the related specialties of molecular, toxicology, oncology, and immunology from hospitals, private laboratories, academic institutions, and the government will be in attendance. We are continually setting records for attendance and the number of exhibitors over the past several years and look forward to doing the same in 2019.
Request A Demo

Biocartis is recruiting centers for a prospective biomarker study comparing turnaround times of standard of care methods and biomarker testing with Idylla™.

One of the biggest challenges oncology labs face with biomarker testing is the ability to obtain samples of sufficient size and quality. With the Idylla™ system only a minimal amount of sample is needed. For solid biopsies, just one slice of tissue is enough and our plasma-based assays require only 1 ml of plasma.